The post FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics appeared first on Hospital Management.
FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics
Hospital Management
·
·
15 views
The US FDA has granted breakthrough device designation to Glytec’s proposed insulin dosing recommendation algorithm, Glucommander Pediatrics, for hospitalised newborns and infants under two years old. The post FDA grants breakthrough designation to Glytec’s Glucommander Pediatrics appeared first on Hospital Management.
TechPlanet 
Japan Industry News 
My Money Blog 
North Shore TMS Blog 
MedCity News 
